PCAR Stock Analysis: PACCAR | NASDAQ
Farm & Heavy Construction Machinery | NASDAQ, USA | Market Cap: 56.837m USD | 12M Return: 19.9% | US6937181088 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 419M
EPS Trend: -89.8%
Qual. Beats: 0
Rev. Trend: -93.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
PACCAR Inc is a global manufacturer and distributor of light, medium, and heavy-duty commercial trucks, operating through three segments: Truck, Parts, and Financial Services. The Truck segment produces over-the-road and off-highway hauling vehicles and diesel engines, selling under the Kenworth, Peterbilt, and DAF nameplates through an independent dealer network. The Parts segment distributes aftermarket parts for commercial trucks and related vehicles, while the Financial Services segment conducts full-service leasing under the PacLease brand and provides financing to customers, dealers, and independent truck owners/operators. The company also manufactures and markets industrial winches under the Braden, Carco, and Gearmatic nameplates, and was founded in 1905, with its headquarters in Bellevue, Washington.
As a large-cap Industrials company listed on NASDAQ, PACCAR operates in the heavy transportation equipment subsector, which is closely tied to global freight demand, commercial vehicle replacement cycles, and economic conditions affecting logistics and construction activity. Its vertically integrated model, combining manufacturing, parts distribution, and captive financing, is characteristic of major heavy-truck OEMs and provides recurring revenue streams that can help offset cyclical truck sales.
- Class 8 truck orders weaken amid freight recession
- Parts segment margins expand with installed base growth
- EPA emissions rules drive pre-buy cycle for new trucks
| Net Income: 2.50b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.59 > 1.0 |
| NWC/Revenue: 84.31% < 20% (prev 73.57%; Δ 10.74% < -1%) |
| CFO/TA 0.10 > 3% & CFO 4.34b > Net Income 2.50b |
| Net Debt (6.00b) to EBITDA (3.77b): 1.59 < 3 |
| Current Ratio: 3.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (527.6m) vs 12m ago 0.17% < -2% |
| Gross Margin: 14.86% > 18% (prev 18.15%; Δ -3.29% > 0.5%) |
| Asset Turnover: 61.93% > 50% (prev 70.53%; Δ -8.60% > 0%) |
| Interest Coverage Ratio: 8.50 > 6 (EBIT TTM 2.94b / Interest Expense TTM 346.5m) |
| A: 0.52 (Total Current Assets 33.9b - Total Current Liabilities 10.9b) / Total Assets 44.0b |
| B: 0.45 (Retained Earnings 19.7b / Total Assets 44.0b) |
| C: 0.07 (EBIT TTM 2.94b / Avg Total Assets 44.0b) |
| D: 0.86 (Book Value of Equity 20.3b / Total Liabilities 23.7b) |
| Altman-Z'' = 6.24 = AAA |
| DSRI: 1.10 (Receivables 21.7b/22.4b, Revenue 27.3b/31.1b) |
| GMI: 1.22 (GM 18.15% / 14.86%) |
| AQI: 1.05 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 0.88 (Revenue 27.3b / 31.1b) |
| TATA: -0.04 (NI 2.50b - CFO 4.34b) / TA 44.0b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of October 19, 2026, the stock is trading at USD 110.82 with a total of 2,945,122 shares traded. Over the past week, the price has changed by +2.57%, over one month by -5.57%, over three months by -11.95% and over the past year by +19.92%.
Current recommended Stop Loss: 104.50 (which is 5.7% or 2.5 ATR below the current price).
PACCAR has received a consensus analysts rating of 3.79. Therefore, it is recommended to hold PCAR.
- StrongBuy: 6
- Buy: 3
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 135.1 | 21.9% |
P/E Trailing = 22.7806
P/E Forward = 15.0602
P/S = 2.0433
P/B = 2.9034
P/EG = 0.8317
Revenue TTM = 27.3b USD
EBIT TTM = 2.94b USD
EBITDA TTM = 3.77b USD
Long Term Debt = 9.91b USD (from longTermDebt, last quarter)
Short Term Debt = 4.79b USD (from shortTermDebt, last quarter)
Debt = 14.8b USD (from shortLongTermDebtTotal, last quarter) + Leases 142.6m
Net Debt = 6.00b USD (calculated: Debt 14.8b - CCE 8.83b)
Enterprise Value = 62.8b USD (56.8b + Debt 14.8b - CCE 8.83b)
Interest Coverage Ratio = 8.50 (Ebit TTM 2.94b / Interest Expense TTM 346.5m)
EV/FCF = 20.05x (Enterprise Value 62.8b / FCF TTM 3.13b)
FCF Yield = 4.99% (FCF TTM 3.13b / Enterprise Value 62.8b)
FCF Margin = 11.49% (FCF TTM 3.13b / Revenue TTM 27.3b)
Net Margin = 9.18% (Net Income TTM 2.50b / Revenue TTM 27.3b)
Gross Margin = 14.86% ((Revenue TTM 27.3b - Cost of Revenue TTM 23.2b) / Revenue TTM)
Gross Margin QoQ = 16.07% (prev 13.12%)
Tobins Q-Ratio = 1.43 (Enterprise Value 62.8b / Total Assets 44.0b)
Interest Expense / Debt = 2.34% (Interest Expense 346.5m / Debt 14.8b)
Taxrate = 16.82% (506.2m / 3.01b)
NOPAT = 2.45b (EBIT 2.94b * (1 - 16.82%))
Current Ratio = 3.12 (Total Current Assets 33.9b / Total Current Liabilities 10.9b)
Debt / Equity = 0.73 (Debt 14.8b / totalStockholderEquity, last quarter 20.3b)
Debt / EBITDA = 1.59 (Net Debt 6.00b / EBITDA 3.77b)
Debt / FCF = 1.92 (Net Debt 6.00b / FCF TTM 3.13b)
Total Stockholder Equity = 19.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.69% (Net Income 2.50b / Total Assets 44.0b)
RoE = 12.73% (Net Income TTM 2.50b / Total Stockholder Equity 19.7b)
RoCE = 9.95% (EBIT 2.94b / Capital Employed (Equity 19.7b + L.T.Debt 9.91b))
RoIC = 6.70% (NOPAT 2.45b / Invested Capital 36.5b)
WACC = 6.92% (E(56.8b)/V(71.7b) * Re(8.22%) + D(14.8b)/V(71.7b) * Rd(2.34%) * (1-Tc(0.17)))
Discount Rate = 8.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 87.90 | Cagr: 0.11%
[DCF] Terminal Value 76.53% ; FCFF base≈3.03b ; Y1≈3.27b ; Y5≈3.98b
[DCF] Fair Price = 104.6 (EV 61.1b - Net Debt 6.00b = Equity 55.1b / Shares 526.4m; r=8.35% [WACC [floored]]; 5y FCF grow 8.82% → 2.50% )
EPS Correlation: -89.84 | EPS CAGR: -25.38% | SUE: 0.44 | # QB: 0
Revenue Correlation: -93.35 | Revenue CAGR: -10.07% | SUE: 0.68 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.60 | Chg30d=-0.06% | Revisions=+17% | Analysts=12
EPS current Year (2026-12-31): EPS=5.96 | Chg30d=-0.41% | Revisions=+50% | GrowthEPS=+32.1% | GrowthRev=+9.2%
EPS next Year (2027-12-31): EPS=7.14 | Chg30d=-1.15% | Revisions=+40% | GrowthEPS=+19.8% | GrowthRev=+10.2%
[Analyst] Revisions Ratio: +55% (up=7, down=1)